A patient pulls up her phone mid-consultation with a Korean skincare routine, a specific device in mind, or treatment that was rarely part of the conversation a few years ago. South Korea has built one of the world's most competitive aesthetic markets, and its influence now reaches patients well outside Seoul.
That raises a practical question for North American providers: which of these shifts belong in a treatment menu, and which technologies and approaches respond to them? Here is what providers need to know.
South Korea has one of the world’s most developed aesthetics markets. The latest International Society of Aesthetic Plastic Surgery (ISAPS) Global Survey ranks South Korea No. 5 worldwide in the estimated number of plastic surgeons, with 2,808 practicing in the country. Globally, aesthetic procedures have also continued to expand, reaching nearly 38 million in 2024.
That demand supports a substantial—and growing—technology market. Mordor Intelligence estimates South Korea’s aesthetic devices market at $567.8 million in 2026 and projects it will reach $838.6 million by 2031, representing an 8.11% CAGR.
But Korea’s influence does not stop at its borders. Treatments and technologies that gain traction there increasingly reach patients around the world through social media, beauty media, and international travel—often before they become common requests in North American consultation rooms.
For providers, that means a technology arriving as a patient request may already have an established track record in Korea. Paying attention to those signals is less about chasing the latest trend and more about recognizing where patient interest may be heading next.
Korea’s influence extends beyond specific treatments or devices. It is part of a broader shift in how patients approach aesthetics: less as a one-time correction and more as an ongoing strategy for skin quality, maintenance, and prevention.
One hallmark of the Korean approach is combination treatment. Rather than relying on a single modality to address every concern, providers combine technologies and treatments that work in different ways or at different tissue depths.
A 2025 survey of Korean board-certified dermatologists published in Annals of Dermatology found that HIFU and radiofrequency were the most commonly used energy-based devices and were often combined with injectables as part of individualized rejuvenation strategies.
More broadly, 2026 reporting from Vogue identifies “treatment stacking,” the strategic use of multiple modalities to address different concerns, as an approach emerging from South Korea.
Another defining part of the Korea Effect is a skin-quality-first approach to rejuvenation. Korean aesthetic practice has placed significant emphasis on treatments designed to improve texture, hydration, elasticity, and fine lines—not simply lift, fill, or otherwise correct visible signs of aging.
That philosophy is evident in the widespread use of skin boosters such as polynucleotides (PN). A 2024 survey of Korean board-certified dermatologists found that 88% used injectable PN, with common indications including uneven texture, dry skin, and facial fine lines. Most PN users also combined it with other modalities, including radiofrequency and HIFU, reinforcing the broader Korean approach of pairing skin regeneration with complementary technologies.
The Korean approach is also helping shift the conversation from anti-aging to “slow aging,” maintaining skin health consistently over time rather than waiting to correct more advanced signs of aging. Vogue describes slow aging as a core K-beauty philosophy, centered on preventative, routine-based care and long-term skin quality rather than quick fixes.
That mindset is increasingly resonating with younger consumers: 2026 data from Korean beauty platform Hwahae showed its Slow Aging category grew 70% year over year, with purchasing growth among consumers in their 20s outpacing those in their 40s.
Together, those trends point to a more proactive approach—starting skin maintenance earlier and treating it as an ongoing part of aesthetic care rather than a response to visible aging.
The Korea Effect is not limited to facial rejuvenation. Seoul’s aesthetics market also reflects growing interest in targeted, non-surgical body treatments. In 2026, British Vogue reported on the range of body-contouring treatments available in South Korea, including energy-based technologies for areas such as the abdomen, arms, and thighs.
None of this requires abandoning a practice's existing treatment philosophy. It does mean the technologies and treatments capable of supporting layered, individualized plans, from regeneration and skin quality to multi-depth energy delivery and body contouring, are becoming increasingly relevant to where aesthetics is headed.
As patient expectations shift toward more comprehensive, ongoing treatment plans, the opportunity for providers is not simply to add more devices. It’s to build a treatment menu with different tools for different goals: technologies that work across tissue depths; regenerative options focused on skin quality; and targeted treatments for both the face and body.
Cartessa’s portfolio includes technologies developed by South Korea–based Classys, global innovations that have gained traction in Korea, and regenerative offerings that speak to the same skin-quality-first philosophy. Together, they illustrate several ways providers can translate the trends above into practice.
For patients seeking non-invasive lifting and tightening, different energy modalities can address different levels of tissue.
EVERESSE, manufactured by South Korea–based Classys, uses 6.78 MHz monopolar radiofrequency to deliver thermal energy across both layers of the dermis while protecting the epidermis. Continuous water cooling is designed to improve patient comfort, while consistent energy delivery enables treatment across multiple dermal depths.
Published data also support its clinical profile. A 2024 study of Volnewmer®, the platform marketed as EVERESSE in North America, found measurable improvement in skin laxity over 12 weeks. More than four in five patients reported being satisfied with their results, while average pain ratings remained low at 1.94.
Ultraformer MPT, also manufactured by Classys, extends treatment deeper with high-intensity focused ultrasound. Four cartridges deliver energy across the upper and lower dermis, subcutaneous tissue, and SMAS, enabling providers to tailor treatment to different anatomical layers. Ultraformer MPT is available exclusively in Canada through Cartessa Aesthetics.
Used independently or as part of a broader treatment strategy, the two technologies illustrate the logic behind layered treatment planning: matching the modality and treatment depth to the concern rather than asking one technology to do everything.
The same thinking applies when the goal is skin quality rather than structural lifting. Texture, enlarged pores, acne scarring, pigmentation, and laxity can involve different layers of the skin, creating a role for technologies designed to work across more than one depth.
QUADESSY, manufactured by Classys and available in the U.S. exclusively through Cartessa, combines non-invasive and minimally invasive radiofrequency in a single RF microneedling platform. Its DualDepth™ technology delivers synchronized RF energy across the epidermis, papillary dermis, and reticular dermis in a single pulse, reducing the need for repeated passes and cutting treatment times by more than 50% compared with conventional RF microneedling systems.
Adaptive Energy Control™ adds real-time impedance monitoring, automatically adjusting RF output as tissue conditions change to support more consistent energy delivery. For providers, that combination expands the skin-quality conversation beyond a single concern and toward a more comprehensive remodeling strategy.
The regenerative trend highlighted by the popularity of PN in Korea also creates a role for regenerative and regenerative-adjacent treatments within the broader aesthetic plan. Chronos EXO CR is an exosome-based biologic designed to support skin regeneration and is used topically in combination with procedures including microneedling and laser resurfacing.
Exosomes and PN are distinct technologies, but both reflect the broader shift toward treatments focused on skin quality, biological renewal, and complementary treatment strategies.
The same move toward targeted energy delivery extends beyond the face.
ONDA PRO is a useful example of how the Korea Effect extends beyond Korean-made technology. Manufactured in Italy by El.En. SpA, the parent company of DEKA, ONDA PRO has gained visibility in Korean aesthetic clinics and is now available exclusively through Cartessa Aesthetics in the U.S. and Canada.
The platform is the only aesthetic treatment powered by Coolwaves® technology, and uses 2.45 GHz Coolwaves® microwave technology to target subcutaneous tissue while limiting energy at the skin’s surface. Three handpieces deliver energy at selective depths and across different anatomical areas.
Together, these technologies and treatments reflect different parts of the same evolution: more individualized treatment planning, complementary modalities, greater attention to skin quality and regeneration, treatment across multiple tissue depths, and an aesthetic strategy that can extend from the face to the body.
Responding to evolving patient expectations does not require rebuilding a treatment menu all at once. A more strategic approach is to look across the concerns patients are bringing into the practice and identify where different technologies and treatments can expand or complement what is already being offered.
The solutions discussed here illustrate different roles within that framework:
These are not interchangeable solutions. Each fills a different role within a broader treatment strategy, while trends such as slow aging are reflected less in a single technology than in how treatments are planned over time.
The broader opportunity is to build a menu with enough range to support more individualized strategies: structural lifting where it is needed, multi-layer skin remodeling, regenerative options, and targeted body treatments.
For a closer look at the engineering behind some of these platforms, explore The Technologies Behind Korea's Most Sought-After Treatments.
Responding to shifts in patient demand is easier with a partner that evaluates technologies independently rather than around a single manufacturer’s roadmap. Cartessa selects platforms against the same core standards: clinical efficacy, patient experience, and achievable ROI, then supports practices with clinical training, marketing resources, and hands-on practice development.
If the Korea Effect is already shaping the questions patients bring into your practice, Cartessa can help you evaluate where your treatment menu is ready and where there may be room to evolve. Contact the Cartessa team today.